Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis-Reference-Cited by-同舟云学术

Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis

Published:2009-08-25 Issue:8 Volume:120 Page:699-708
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Norata Giuseppe Danilo¹,Marchesi Patrizia¹,Pulakazhi Venu Vivek Krishna¹,Pasqualini Fabio¹,Anselmo Achille¹,Moalli Federica¹,Pizzitola Irene¹,Garlanda Cecilia¹,Mantovani Alberto¹,Catapano Alberico Luigi¹

Affiliation:

1. From the Departments of Pharmacological Sciences (G.D.N., P.M., V.K.P.V., I.P., A.L.C.) and Translational Medicine (A.M.), Università degli Studi di Milano, Milan; Center for the Study of Atherosclerosis, Società Italiana Studio Aterosclerosi, Ospedale Bassini, Cinisello Balsamo (G.D.V., A.L.C.); and Istituto Clinico Humanitas, IRCCS, Rozzano, Milan (F.P., A.A., F.M., C.G., A.M.), Italy.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference44 articles.

1. The immune response in atherosclerosis: a double-edged sword

2. Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein

3. PENTRAXINS AT THE CROSSROADS BETWEEN INNATE IMMUNITY, INFLAMMATION, MATRIX DEPOSITION, AND FEMALE FERTILITY

4. The Verdict Is Still Out

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pentraxin-3 and atherosclerosis risk: a Mendelian randomization study;2024-01-18

2. Role of High-sensitivity C-reactive Protein in Future Cardiovascular Events in Hemodialysis Patients;In Vivo;2024

3. Pentraxin 3: A promising therapeutic target for cardiovascular diseases;Ageing Research Reviews;2024-01

4. Nonlinear associations between computed tomography‐measures of adiposity and long pentraxin‐3 in the Multi‐Ethnic Study of Atherosclerosis;Obesity Science & Practice;2023-11-13

5. The pentraxin family in autoimmune disease;Clinica Chimica Acta;2023-11